Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6847342 | 0.91 | MEN1 (0.31) | ALDH1A1 | |
| SCHEMBL25217270 | 0.77 | LMNA (0.32) | CYP2C19RAB9ASMN1; SMN2 | |
| SCHEMBL3719747 | 0.76 | ALDH1A1 (0.34) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL32675817 | 0.75 | TSHR (0.32) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL3485305 | 0.73 | ALDH1A1 (0.32) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| Water SCHEMBL6913374 | 0.72 | ALDH1A1 (0.31) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| Ethylene Glycol SCHEMBL413417 | 0.72 | ALDH1A1 (0.31) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| Ethylene Glycol SCHEMBL10584826 | 0.72 | ALDH1A1 (0.31) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL7762150 | 0.70 | KMT2A (0.36) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL712704 | 0.70 | ECE1 (0.32) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119335172-A | Whole blood visual colorimetric test strip for detecting multiple biomarkers | 万有生化智能科技(深圳)有限公司 | 2025-01-21 | — | — | CN | disclosed |
| US-20110177617-A1 | CROSS-LINKING REAGENTS FOR MOLECULAR INTERACTIONS ANALYSIS | ETH ZURICH (CH) | 2011-07-21 | — | — | US | disclosed |
| US-6004764-A | SCREENING METHODS FOR POTENTIAL THERAPEUTIC AGENTS WHICH REGULATE THE GROWTH OF M. TUBERCULOSIS; METHOD FOR IDENTIFYING GENES OF M. TUBERCULOSIS WHICH ARE REGULATED BY A SIGMA FACTOR OF M. TUBERCULOSIS | JOHNS HOPKINS UNIVERSITY (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0910403-A1 | STATIONARY PHASE, STRESS RESPONSE SIGMA FACTOR FROM MYCOBACTERIUM TUBERCULOSIS, AND REGULATION THEREOF | THE JOHNS-HOPKINS UNIVERSITY (US) | 1999-04-28 | — | — | EP | disclosed |
| WO-1997035611-A1 | STATIONARY PHASE, STRESS RESPONSE SIGMA FACTOR FROM MYCOBACTERIUM TUBERCULOSIS, AND REGULATION THEREOF | THE JOHNS-HOPKINS UNIVERSITY (US) | 1997-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110177617-A1 | CROSS-LINKING REAGENTS FOR MOLECULAR INTERACTIONS ANALYSIS | MTCL3, BICRA, HMGB3 | ALDH1A1 2627/4885CYP2D6 1678/4885TSHR 3927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.